| Standard Practice (N = 104) | Polypill (N = 99) |  |  | ||||
---|---|---|---|---|---|---|---|---|
 | Baseline | Exit | Diff | Baseline | Exit | Diff | Diff of Differences (95% CI) | P-value |
Estimated 10-year CVD risk (%) | 41.6 ± 19.8 | 11.1 ± 10.0 | -30.6 ± 22.8 | 44.1 ± 20.3 | 11.5 ± 13.0 | -32.7 ± 26.0 | 2.1 (-4.9, 9.1) | 0.56 |
Systolic blood pressure (mmHg)* | 165.0 ± 17.6 | 138.1 ± 19.3 | -26.9 ± 25.7 | 165.6 ± 19.2 | 136.8 ± 20.8 | -28.8 ± 24.9 | 1.9 (-5.1, 8.9) | 0.60 |
Total cholesterol (mmol/L) | 5.7 ± 1.3 | 4.7 ± 1.1 | -1.0 ± 1.6 | 6.1 ± 1.3 | 4.8 ± 1.0 | -1.4 ± 1.2 | 0.4 (0.0, 0.8) | 0.07 |
Creatinine (mmol/L) | 90.5 ± 21.2 | 92.8 ± 24.6 | 1.3 ± 19.3 | 87.8 ± 22.6 | 92.9 ± 25.9 | 4.8 ± 31.7 | -3.5 (-10.8, 3.8) | 0.36 |
Serum potassium (mmol/L) | 4.6 ± 0.6 | 4.5 ± 0.4 | -0.0 ± 0.5 | 4.5 ± 0.5 | 4.6 ± 0.5 | 0.1 ± 0.6 | -0.1 (-0.3, 0.1) | 0.10 |
Alanine aminotransferase (U/L) | 31.9 ± 18.2 | 36.3 ± 31.6 | 4.1 ± 25.7 | 29.8 ± 15.0 | 33.0 ± 26.0 | 3.0 ± 17.8 | 1.1(-5.1, 7.3) | 0.72 |